Risk and Reward in the Orphan Drug Industry
© 2019 Portfolio Management Research. All rights reserved. Thanks to a combination of scientific advances and economic incentives, the development of therapeutics to treat rare or orphan diseases has grown dramatically in recent years. With the advent of Food and Drug Administration–approved gene th...
| Egile Nagusiak: | , |
|---|---|
| Formatua: | Artikulua |
| Hizkuntza: | English |
| Argitaratua: |
Pageant Media US
2021
|
| Sarrera elektronikoa: | https://hdl.handle.net/1721.1/134802 |